Daniela Perez

San Miguel De Tucuman, T, Argentina

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Immune-mediated adverse events following atezolizumab and bevacizumab in a multinational Latin American cohort of unresectable hepatocellular carcinoma.

Immune-mediated adverse events following atezolizumab and bevacizumab in a multinational Latin American cohort of unresectable hepatocellular carcinoma.

Journal: Oncotarget

Published: May 19, 2025

Hepatocellular Carcinoma: Epidemiological Reality in Tucumán, Argentine Northwest

Hepatocellular Carcinoma: Epidemiological Reality in Tucumán, Argentine Northwest

Journal: Acta gastroenterologica Latinoamericana

Published: July 31, 2023

Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC.

Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC.

Journal: Annals of hepatology

Published: February 03, 2023

Norfloxacin prophylaxis effect on multidrug resistance in patients with cirrhosis and bacterial infections.

Norfloxacin prophylaxis effect on multidrug resistance in patients with cirrhosis and bacterial infections.

Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

Published: August 23, 2022

Failure in all steps of hepatocellular carcinoma surveillance process is frequent in daily practice.

Failure in all steps of hepatocellular carcinoma surveillance process is frequent in daily practice.

Journal: Annals of hepatology

Published: December 28, 2020

Decompensated cirrhosis and liver transplantation negatively impact in DAA treatment response: Real-world experience from HCV-LALREAN cohort.

Decompensated cirrhosis and liver transplantation negatively impact in DAA treatment response: Real-world experience from HCV-LALREAN cohort.

Journal: Journal of medical virology

Published: June 14, 2020

Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents.

Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: October 03, 2019

The ECHO model proved to be a useful tool to increase clinicians' self-effectiveness for care of patients with Hepatitis C in Argentina.

The ECHO model proved to be a useful tool to increase clinicians' self-effectiveness for care of patients with Hepatitis C in Argentina.

Journal: Journal of viral hepatitis

Published: April 02, 2019

Treatment with direct-acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma.

Treatment with direct-acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: September 21, 2018

Showing 1-9 of 9

Last Updated: 09/26/2026